Version française

Stago at the Heart of Haemostasis

People dedicated to Health

From ideas...to medical applications

Complications of heparin treatment

In the absence of any straightforward laboratory tests, the most severe complication, known as type II heparin-induced thrombocytopenia (HIT) has...

From ideas...to medical applications

STA-Procoag-PPL or making microparticles talk

Midway between plasma haemostasis and cellular haemostasis are microparticles, rich in procoagulant phospholipids. An increase in this procoagulant...

From ideas...to medical applications

Remaining abreast of changes in biomedical science

Listening to and exchanging ideas with members of the biomedical science community has enabled Stago to develop its expertise in the search for...

From ideas...to medical applications

Complete industrial autonomy

Achieving a balanced policy with regard to investment in research & development (R&D), technological monitoring and rational acquisitions is a key...

Tablets App

android appiPad App

This free educational application in English is the first of its kind and has been developed by an expert in Haemostasis… Stago.

Products & Services

Comprehensive system for Factor XIII antigenic measurement – K-Assay Factor XIII line (1)

As part of our strategy is to offer a comprehensive reagent portfolio, Stago is pleased to announce we now offer a NEW SOLUTION for automated FXIII assay: the K-Assay Factor XIII line is a complete system for Factor XIII antigenic...

Stago Catalogue

Did you know?

In 1953, Dr R. Langdell et al. proposed a plasma clotting test that could be used for assaying antihaemophilic factor. They designated their one-stage test as "partial thromboplastin time".

RSS feed | Contact us | Credits and copyrights | Disclaimer | Site map | Cookies